TRUMF (Terumo) Issuance of Debt : $759 Mil (TTM As of Sep. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Terumo Issuance of Debt?

Terumo's Issuance of Debt for the three months ended in Sep. 2024 was $0 Mil.

Terumo's Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2024 was $759 Mil.

Terumo Issuance of Debt Historical Data

The historical data trend for Terumo's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Terumo Issuance of Debt Chart

Terumo Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Issuance of Debt

Get a 7-Day Free Trial

371.52

643.98

5.07

Terumo Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Issuance of Debt	Get a 7-Day Free Trial															-	-	-	758.87	-

Terumo Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $759 Mil.

Terumo Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Terumo's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Terumo Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Terumo Corp (OTCPK:TRUMF) » Definitions » Issuance of Debt

Comparable Companies

Traded in Other Exchanges

TRUMY:USA 4543:Mexico 4543:Japan TUO:Germany

Address

2-44-1 Hatagaya, Shibuya-ku, Tokyo, JPN, 151-0072

Website

https://www.terumo.com

Terumo Corp manufactures and sells medical products and equipment. The firm has three main businesses: blood management, cardiac and vascular, and general hospital. The cardiac and vascular business generates the largest proportion of revenue and sells cardiac and endovascular interventional therapies, cardiovascular surgical systems, neurovascular products, and vascular graft products. The general hospital business includes diabetes management, consumer healthcare, drug and device technologies, and general hospital products. The blood management business sells blood component, therapeutic apheresis, and cellular technologies. Terumo generates the majority of its revenue in Asia, with Japan contributing the largest proportion of Asian revenue.